Aug 2026· Journal of Chemical Information and Modeling· Vol 66, pp. 10847 - 10861· 0 citations· 92 references
Medicine
TL;DR
PockLigGPT achieves competitive docking-oriented performance under a standardized evaluation protocol while maintaining chemical plausibility, favorable physicochemical profiles, and Lipinski-based drug-likeness.
Abstract
De novo drug design aims to generate molecules targeting specific protein pockets while retaining chemical plausibility and drug-like properties. Recent 3D structure-based generative methods explicitly model pocket-ligand geometry, but this does not always translate into chemically realistic or practically usable candidate molecules. Molecular language models provide a complementary sequence-based alternative. However, it remains unclear whether sequence-based pocket information can effectively guide ligand generation, whether multistage training improves pocket-specific generation, and whether docking-guided reinforcement learning can be integrated into a practical generation pipeline. We introduce PockLigGPT, a GPT-based framework for pocket-sequence-conditioned molecular generation. Rather than producing fixed 3D coordinates, PockLigGPT formulates ligand design as a sequence-generation problem conditioned on the amino acid composition of the protein pocket. The model is trained in four stages: large-scale chemical pretraining based on ZINC20; bioactivity-oriented adaptation based on ChEMBL; pocket-sequence-conditioned fine-tuning using binding-pocket amino acid sequences paired with ligands; and, finally, pocket-specific docking-guided reinforcement learning using AutoDock Vina-based rewards. PockLigGPT achieves competitive docking-oriented performance under a standardized evaluation protocol while maintaining chemical plausibility, favorable physicochemical profiles, and Lipinski-based drug-likeness. Docking studies on Alzheimer’s disease-associated targets and token-level analyses further support the utility of PockLigGPT for de novo drug design.
Drug discovery and development is time-consuming and resource-intensive, motivating computational approaches such as diffusion models for de novo drug design. Many such models follow the structure-based drug design (SBDD) paradigm, generating molecules to fit a target binding pocket. However, existing diffusion-based S...
A clear pattern is revealed in LLM spatial capabilities: while they still lag behind state-of-the-art approaches, they are promising and can handle multiple spatial constraints simultaneously, enabling scaling to heterogeneous setups.
Thomas MacDougall, Maksim Kuznetsov, Roman Schutski et al.· arXiv.org· 1 citation
This work proposes LLMol, a principled reinforcement learning framework that directly incorporates verifiable rewards for targeted molecule generation and introduces Reinforcement Learning with Verifiable Rewards (RLVR), which directly integrates property-based reward signals to guide molecular generation toward task-s...
MolecularCanvas is an interactive system that enables users to iteratively construct an optimization context by integrating high-level goals, structure-level annotations, property constraints, and reference-based preferences that guides the generation of candidate molecules across diverse molecular structures.
Haoyu Dong, Rui Sheng, Shu-Hao Zhang et al.· 0 citations
PGFS++ is introduced, a synthesis-aware reinforcement learning framework for input-specific molecular improvement that improves target properties while preserving high output diversity, and experiments show that PGFS++ improves target properties while preserving high output diversity.
Bo-Qi Zhang, G. James, S. Gottipati et al.· 0 citations
The resulting model, HydrAffinity, is an interaction-free, dynamic sparse model that uses pre-trained encoders and MoE for parameter-efficient learning and outperforms all interaction-free methods and matches state-of-the-art interaction-based methods on CASF-2016.
Huiming Bao, Shouliang Dong· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.